✦ LIBER ✦

Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital's Experience

✍ Scribed by Jeremy F. Sturgeon; Malcolm J. Moore; David M. Kakiashvili; Ignacio Duran; Lynn C. Anson-Cartwright; Dominik R. Berthold; Padraig R. Warde; Mary K. Gospodarowicz; Ruth E. Alison; Justin Liu; Clement Ma; Greg R. Pond; Michael A. Jewett

Book ID: 113612140
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 268 KB
Volume: 59
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NON-RISK ADAPTED SURVEILLANCE IN STAGE I

NON-RISK ADAPTED SURVEILLANCE IN STAGE I NONSEMINOMATOUS GERM CELL TUMOURS (NSGCT): IMPROVED RECENT OUTCOMES

✍ M. Jewett; M. Moore; P. Warde; L. Anson-Cartwright; D. Kakiashvili; D. Berthold; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Outcomes of Surveillance Protocol of Cli

Outcomes of Surveillance Protocol of Clinical Stage I Nonseminomatous Germ Cell Tumors—Is Shift to Risk Adapted Policy Justified?

✍ Divrik, Rauf Taner; Akdoğan, Bülent; Özen, Haluk; Zorlu, Ferruh 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 105 KB

Risk-adapted treatment for patients with

Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis

✍ Robert J. Amato; Jae Y. Ro; Alberto G. Ayala; David A. Swanson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

RISK ADAPTED MANAGEMENT WITH ADJUVANT CH

RISK ADAPTED MANAGEMENT WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH RISK CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR

✍ STUDER, URS E.; BURKHARD, FIONA C.; SONNTAG, ROLAND W. 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 41 KB

Risk-Adapted Treatment in Clinical Stage

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

✍ Kibel, A.S. 📂 Article 📅 2010 🏛 Elsevier Science ⚖ 45 KB

Report of the long-term efficacy of two

Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group

✍ Aristotelis Bamias; Gerassimos Aravantinos; Ioannis Kastriotis; Gerassimos Alivi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 137 KB